During the past decade, The Central Hospital of Lishui City conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 1 clinical trials were completed. i.e. 4.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Central Hospital of Lishui City" #1 sponsor was "Hepatopancreatobiliary Surgery Institute of Gansu Province" with 4 trials, followed by "Second Affiliated Hospital, School of Medicine, Zhejiang University" with 4 trials sponsored, "Beijing Tiantan Hospital" with 2 trials sponsored, "First Affiliated Hospital of Zhejiang University" with 1 trials sponsored and "Nanfang Hospital of Southern Medical University" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Central Hospital of Lishui City" #1 collaborator was "LanZhou University" with 5 trials as a collaborator, "The Central Hospital of Lishui City" with 5 trials as a collaborator, "Tianjin Second People's Hospital" with 4 trials as a collaborator, "Guangxi Zhuang Autonomous Region" with 3 trials as a collaborator and "The Sixth People's Hospital of Shenyang" with 3 trials as a collaborator. Other collaborators include 69 different institutions and companies that were collaborators in the rest 68 trials.

According to Clinical.Site data, the most researched conditions in "The Central Hospital of Lishui City" are "COVID-19" (2 trials), "Compensated Advanced Chronic Liver Disease" (2 trials), "Hepatocellular Carcinoma" (2 trials), "Ablation" (1 trials) and "Acute Cerebrovascular Accidents" (1 trials). Many other conditions were trialed in "The Central Hospital of Lishui City" in a lesser frequency.

Most popular intervention types in "The Central Hospital of Lishui City" are "Drug" (12 trials), "Procedure" (5 trials), "Device" (3 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "4mg ZOL loaded gentamicin PMMA" (1 trials), "Aspirin 100mg" (1 trials), "Bevacizumab" (1 trials), "CEMR" (1 trials) and "Camrelizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Central Hospital of Lishui City" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "The Central Hospital of Lishui City". undefined are not yet recruiting, 10 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in The Central Hospital of Lishui City, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in The Central Hospital of Lishui City, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 6 trials that are defined as “Not Applicable".